H19 and colorectal carcinoma: LncRNAs contribute to both CRC drug resistance and CRC EMT, for instance, LncRNA H19 was found to be upregulated in CRC cells treated with hypoxia or oxaliplatin, contributing to drug resistance both in vitro and in vivo.